MIDDLESBORO ARH
1. Target Overview & Investment Thesis
MIDDLESBORO ARH is a 46-bed under-performing / distressed in BELL, KY with $36.8M in net patient revenue and a -31.4% operating margin. The hospital serves a payer mix of 27.5% Medicare, 7.0% Medicaid, and 65.5% commercial.
Thesis: Turnaround. Our ML models identify $2.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -31.4% to -24.1% (+736bps).
| Net Revenue HCRIS | $36.8M |
| Current EBITDA COMPUTED | $-11.6M |
| Operating Margin COMPUTED | -31.4% |
| Occupancy HCRIS | 32.0% |
| Revenue / Bed COMPUTED | $801K |
| Net-to-Gross HCRIS | 17.1% |
| Distress Probability ML | 52.0% |
2. Market Context & Competitive Position
KY has 114 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of -31.4% places it below the state median. Among 68 size-comparable peers (23-92 beds), the median margin is -0.3%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (23-92), prioritizing same-state peers. 68 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| MIDDLESBORO ARH (Target) | KY | 46 | $36.8M | -31.4% |
| BAPTIST HEALTH LAGRANGE | KY | 42 | $236.9M | 2.7% |
| CLARK REGIONAL MEDICAL CENTER | KY | 54 | $156.4M | 16.5% |
| BAPTIST HEALTH RICHMOND | KY | 53 | $145.6M | -3.7% |
| GEORGETOWN COMMUNITY HOSPITAL | KY | 75 | $118.5M | 15.1% |
| TAYLOR REGIONAL HOSPITAL | KY | 90 | $109.9M | -6.7% |
| HIGHLANDS REGIONAL MEDICAL CEN | KY | 63 | $96.5M | -32.6% |
| FLAGET MEMORIAL HOSPITAL | KY | 40 | $86.2M | -0.6% |
| ROCKCASTLE HOSPT. & RESPIR CAR | KY | 30 | $79.1M | 2.2% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.7M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $774K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $737K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $729K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $448K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $24K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-11.6M |
| + RCM Uplift | +$2.7M |
| Pro Forma EBITDA | $-8.9M |
| Current Margin | -31.4% |
| Pro Forma Margin | -24.1% |
| WC Released (1x) | $1.4M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-17.8M | $-49.2M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-17.8M | $-59.9M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-16.0M | $-56.8M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-16.0M | $-66.7M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-19.6M | $-57.0M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-19.6M | $-69.1M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Low occupancy | At 32.0%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 52.0% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 68 hospitals with 23-92 beds
- Same-state prioritization (n=69)
- Comp margins: P25=-11.0% / P50=-0.3% / P75=10.3%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.